What is Disc Medicine Inc. (IRON) stock price today?

Disc Medicine Inc. (IRON) currently trades at $65.97 per share. The stock has a market capitalization of $2.52B and a P/E ratio of —x.

Is IRON stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Disc Medicine Inc. has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is 3.92.

Is Disc Medicine Inc. financially healthy?

Disc Medicine Inc.'s Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of 3.92 places it in the safe zone.

IRON

Disc Medicine Inc.

NASDAQ: IRON · HEALTHCARE · BIOTECHNOLOGY

$65.97

-1.92% today

Updated 2026-04-29

Market cap

$2.52B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-6.01

Dividend yield

—

52W range

$40 – $100

Volume

0.5M

Market cap

$2.52B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-6.01

Dividend yield

—

52W range

$40 – $100

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

3.9

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$100.17

+51.84%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 3.92 — safe zone

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-43.32M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$-19.88M
Net income	$-46.09M	$-76.43M	$-109.36M	$-212.18M	$-60.53M
EPS	—	—	—	—	$-6.01
Free cash flow	$-42.40M	$-73.55M	$-94.43M	$-181.33M	$-43.32M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IRON	$2.52B	27	4.3	3.0	5.0	7.3	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Disc Medicine Inc. trades at $65.97. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 3.92, it sits in the safe zone.

Frequently asked questions

What is Disc Medicine Inc.'s stock price?

Disc Medicine Inc. (IRON) trades at $65.97.

Is Disc Medicine Inc. overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Disc Medicine Inc. (IRON)?

The analyst target price is $100.17, representing +51.8% upside from the current price of $65.97.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

3.92 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-35.90%

Beta2.54

50D MA$64.72

200D MA$71.58

Shares out0.04B

Float0.03B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

IRON vs LLY →IRON vs JNJ →IRON vs ABBV →Stock screener →